Short interfering RNAs targeting a vampire-bat related rabies virus phosphoprotein mRNA
Abstract The aim of this study was to assess the in vitro and in vivo effects of short-interfering RNAs (siRNAs) against rabies virus phosphoprotein (P) mRNA in a post-infection treatment for rabies as an extension of a previous report (Braz J Microbiol. 2013 Nov 15;44(3):879-82). To this end, rabie...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Microbiologia
|
Series: | Brazilian Journal of Microbiology |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822017000300566&lng=en&tlng=en |
id |
doaj-d6c8463245b048b3aca42c36e9dca456 |
---|---|
record_format |
Article |
spelling |
doaj-d6c8463245b048b3aca42c36e9dca4562020-11-24T20:41:34ZengSociedade Brasileira de MicrobiologiaBrazilian Journal of Microbiology1678-440548356656910.1016/j.bjm.2016.11.007S1517-83822017000300566Short interfering RNAs targeting a vampire-bat related rabies virus phosphoprotein mRNAEkaterina Alexandrovna Durymanova OnoSueli Akemi TaniwakiPaulo BrandãoAbstract The aim of this study was to assess the in vitro and in vivo effects of short-interfering RNAs (siRNAs) against rabies virus phosphoprotein (P) mRNA in a post-infection treatment for rabies as an extension of a previous report (Braz J Microbiol. 2013 Nov 15;44(3):879-82). To this end, rabies virus strain RABV-4005 (related to the Desmodus rotundus vampire bat) were used to inoculate BHK-21 cells and mice, and the transfection with each of the siRNAs was made with Lipofectamine-2000™. In vitro results showed that siRNA 360 was able to inhibit the replication of strain RABV-4005 with a 1 log decrease in virus titter and 5.16-fold reduction in P mRNA, 24 h post-inoculation when compared to non-treated cells. In vivo, siRNA 360 was able to induce partial protection, but with no significant difference when compared to non-treated mice. These results indicate that, despite the need for improvement for in vivo applications, P mRNA might be a target for an RNAi-based treatment for rabies.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822017000300566&lng=en&tlng=enRabiesTreatmentRNA interference |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ekaterina Alexandrovna Durymanova Ono Sueli Akemi Taniwaki Paulo Brandão |
spellingShingle |
Ekaterina Alexandrovna Durymanova Ono Sueli Akemi Taniwaki Paulo Brandão Short interfering RNAs targeting a vampire-bat related rabies virus phosphoprotein mRNA Brazilian Journal of Microbiology Rabies Treatment RNA interference |
author_facet |
Ekaterina Alexandrovna Durymanova Ono Sueli Akemi Taniwaki Paulo Brandão |
author_sort |
Ekaterina Alexandrovna Durymanova Ono |
title |
Short interfering RNAs targeting a vampire-bat related rabies virus phosphoprotein mRNA |
title_short |
Short interfering RNAs targeting a vampire-bat related rabies virus phosphoprotein mRNA |
title_full |
Short interfering RNAs targeting a vampire-bat related rabies virus phosphoprotein mRNA |
title_fullStr |
Short interfering RNAs targeting a vampire-bat related rabies virus phosphoprotein mRNA |
title_full_unstemmed |
Short interfering RNAs targeting a vampire-bat related rabies virus phosphoprotein mRNA |
title_sort |
short interfering rnas targeting a vampire-bat related rabies virus phosphoprotein mrna |
publisher |
Sociedade Brasileira de Microbiologia |
series |
Brazilian Journal of Microbiology |
issn |
1678-4405 |
description |
Abstract The aim of this study was to assess the in vitro and in vivo effects of short-interfering RNAs (siRNAs) against rabies virus phosphoprotein (P) mRNA in a post-infection treatment for rabies as an extension of a previous report (Braz J Microbiol. 2013 Nov 15;44(3):879-82). To this end, rabies virus strain RABV-4005 (related to the Desmodus rotundus vampire bat) were used to inoculate BHK-21 cells and mice, and the transfection with each of the siRNAs was made with Lipofectamine-2000™. In vitro results showed that siRNA 360 was able to inhibit the replication of strain RABV-4005 with a 1 log decrease in virus titter and 5.16-fold reduction in P mRNA, 24 h post-inoculation when compared to non-treated cells. In vivo, siRNA 360 was able to induce partial protection, but with no significant difference when compared to non-treated mice. These results indicate that, despite the need for improvement for in vivo applications, P mRNA might be a target for an RNAi-based treatment for rabies. |
topic |
Rabies Treatment RNA interference |
url |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822017000300566&lng=en&tlng=en |
work_keys_str_mv |
AT ekaterinaalexandrovnadurymanovaono shortinterferingrnastargetingavampirebatrelatedrabiesvirusphosphoproteinmrna AT sueliakemitaniwaki shortinterferingrnastargetingavampirebatrelatedrabiesvirusphosphoproteinmrna AT paulobrandao shortinterferingrnastargetingavampirebatrelatedrabiesvirusphosphoproteinmrna |
_version_ |
1716824646318292992 |